Cyclacel Pharmaceuticals Preferred Stock Market Value
| CYCCP Preferred Stock | USD 5.80 0.04 0.69% |
| Symbol | Cyclacel |
Cyclacel Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Cyclacel Pharmaceuticals' preferred stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Cyclacel Pharmaceuticals.
| 11/14/2024 |
| 12/14/2024 |
If you would invest 0.00 in Cyclacel Pharmaceuticals on November 14, 2024 and sell it all today you would earn a total of 0.00 from holding Cyclacel Pharmaceuticals or generate 0.0% return on investment in Cyclacel Pharmaceuticals over 30 days. Cyclacel Pharmaceuticals is related to or competes with Checkpoint Therapeutics, Mustang Bio, Reviva Pharmaceuticals, Kodiak Sciences, Fortress Biotech, Achilles Therapeutics, and Aptose Biosciences. Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of canc... More
Cyclacel Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Cyclacel Pharmaceuticals' preferred stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Cyclacel Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.11) | |||
| Maximum Drawdown | 24.03 | |||
| Value At Risk | (9.08) | |||
| Potential Upside | 5.8 |
Cyclacel Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cyclacel Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Cyclacel Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Cyclacel Pharmaceuticals historical prices to predict the future Cyclacel Pharmaceuticals' volatility.| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.33) | |||
| Total Risk Alpha | (0.87) | |||
| Treynor Ratio | 0.7947 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Cyclacel Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Cyclacel Pharmaceuticals Backtested Returns
Cyclacel Pharmaceuticals secures Sharpe Ratio (or Efficiency) of -0.0876, which signifies that the company had a -0.0876% return per unit of standard deviation over the last 3 months. Cyclacel Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Cyclacel Pharmaceuticals' risk adjusted performance of (0.06), and Mean Deviation of 2.27 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of -0.46, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Cyclacel Pharmaceuticals are expected to decrease at a much lower rate. During the bear market, Cyclacel Pharmaceuticals is likely to outperform the market. At this point, Cyclacel Pharmaceuticals has a negative expected return of -0.36%. Please make sure to confirm Cyclacel Pharmaceuticals' value at risk, and the relationship between the jensen alpha and accumulation distribution , to decide if Cyclacel Pharmaceuticals performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.13 |
Insignificant predictability
Cyclacel Pharmaceuticals has insignificant predictability. Overlapping area represents the amount of predictability between Cyclacel Pharmaceuticals time series from 14th of November 2024 to 29th of November 2024 and 29th of November 2024 to 14th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Cyclacel Pharmaceuticals price movement. The serial correlation of 0.13 indicates that less than 13.0% of current Cyclacel Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.13 | |
| Spearman Rank Test | -0.22 | |
| Residual Average | 0.0 | |
| Price Variance | 0.17 |
Cyclacel Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Cyclacel Pharmaceuticals preferred stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Cyclacel Pharmaceuticals' preferred stock expected returns. We can calculate the autocorrelation of Cyclacel Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Cyclacel Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the preferred stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Cyclacel Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Cyclacel Pharmaceuticals preferred stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Cyclacel Pharmaceuticals preferred stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Cyclacel Pharmaceuticals preferred stock over time.
Current vs Lagged Prices |
| Timeline |
Cyclacel Pharmaceuticals Lagged Returns
When evaluating Cyclacel Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Cyclacel Pharmaceuticals preferred stock have on its future price. Cyclacel Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Cyclacel Pharmaceuticals autocorrelation shows the relationship between Cyclacel Pharmaceuticals preferred stock current value and its past values and can show if there is a momentum factor associated with investing in Cyclacel Pharmaceuticals.
Regressed Prices |
| Timeline |
Pair Trading with Cyclacel Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cyclacel Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cyclacel Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving against Cyclacel Preferred Stock
| 0.66 | VAXX | Vaxxinity | PairCorr |
| 0.65 | EVLO | Evelo Biosciences | PairCorr |
| 0.56 | GRCE | Grace Therapeutics, Symbol Change | PairCorr |
| 0.53 | EPRX | Eupraxia Pharmaceuticals | PairCorr |
| 0.51 | FRTX | Fresh Tracks Therapeutics | PairCorr |
The ability to find closely correlated positions to Cyclacel Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cyclacel Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cyclacel Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cyclacel Pharmaceuticals to buy it.
The correlation of Cyclacel Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cyclacel Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cyclacel Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cyclacel Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Cyclacel Preferred Stock Analysis
When running Cyclacel Pharmaceuticals' price analysis, check to measure Cyclacel Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cyclacel Pharmaceuticals is operating at the current time. Most of Cyclacel Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Cyclacel Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cyclacel Pharmaceuticals' price. Additionally, you may evaluate how the addition of Cyclacel Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.